By Vijay Kumar Malesu Reviewed by Susha Cheriyedath, M.Sc. Apr 16 2026 AI is no longer just a support tool in drug development. This paper shows how it could help build faster, smarter, and more personalized cancer therapies, while also exposing the scientific and regulatory hurdles that still stand in the way. Study: Precision oncology in the age of AI: lessons from AI-driven drug discovery and clinical translation . Image Credit: FOTOGRIN / Shutterstock In a recent Perspective article